Variant report
Variant | esv1792986 |
---|---|
Chromosome Location | chr7:71807474-71809414 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:3)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:3 , 50 per page) page:
1
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
CALN1 | TF binding region |
ENSG00000183166 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12539988 | chr7:71807474-71807475 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs577404868 | chr7:71807507-71807508 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs34171746 | chr7:71807522-71807523 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs539382120 | chr7:71807545-71807546 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs544736517 | chr7:71807549-71807550 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs557365014 | chr7:71807553-71807554 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs540083043 | chr7:71807558-71807559 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs183172020 | chr7:71807579-71807580 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs377609805 | chr7:71807680-71807681 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs573177854 | chr7:71807707-71807708 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs75859468 | chr7:71807742-71807743 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs188049379 | chr7:71807745-71807746 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs150661301 | chr7:71807755-71807756 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs372469345 | chr7:71807758-71807759 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs562967246 | chr7:71807771-71807772 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs191568970 | chr7:71807785-71807786 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs573889058 | chr7:71807804-71807805 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs368052911 | chr7:71807807-71807808 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs560520593 | chr7:71807824-71807825 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs369837707 | chr7:71807840-71807841 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs540114033 | chr7:71807846-71807847 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs1914379 | chr7:71807865-71807866 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs374601761 | chr7:71807894-71807895 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs546872722 | chr7:71807912-71807913 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs140954461 | chr7:71807953-71807954 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs535608227 | chr7:71807954-71807955 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs144890075 | chr7:71807956-71807957 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs568917688 | chr7:71807964-71807965 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs10267518 | chr7:71808000-71808001 | Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs557328067 | chr7:71808028-71808029 | Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs36104871 | chr7:71808047-71808048 | Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs551080780 | chr7:71808086-71808087 | Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs533546523 | chr7:71808099-71808100 | Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs182491429 | chr7:71808113-71808114 | Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs574268823 | chr7:71808149-71808150 | Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs112053609 | chr7:71808158-71808159 | Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs575930883 | chr7:71808160-71808161 | Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs139403306 | chr7:71808170-71808171 | Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs562970563 | chr7:71808171-71808172 | Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs186823805 | chr7:71808188-71808189 | Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs192457038 | chr7:71808206-71808207 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs558227566 | chr7:71808218-71808219 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs543208451 | chr7:71808251-71808252 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs561601591 | chr7:71808292-71808293 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs560580416 | chr7:71808300-71808301 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs542152366 | chr7:71808326-71808327 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs149880020 | chr7:71808342-71808343 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs376957671 | chr7:71808360-71808361 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs374700525 | chr7:71808361-71808362 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs549418254 | chr7:71808377-71808378 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Biliary cancer | 19435499 | CNVD |
Williams-beuren syndrome | 22470819 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Cancer | 21183584 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Gastric cancer | 24379144 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Lissencephaly | 21572526 | CNVD |
Breast cancer | 17603634 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Astrocytoma | 22246337 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16461572 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Multiple myeloma | 17550852 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Bladder cancer | 21909424 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164920 | CNVD |
Prostate cancer | 18632612 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Chordoma | 18071362 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21990379 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Williams Syndrome | 16773131 | CNVD |
Breast cancer | 16417655 | CNVD |
Rheumatoid arthritis | 21728841 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 18414209 | CNVD |
Developmental delay | 21549014 | CNVD |
Mental retardation | 18414209 | CNVD |
Mental retardation | 21549014 | CNVD |
Williams Syndrome | 16617304 | CNVD |
Williams Syndrome | 20206275 | CNVD |
Williams Syndrome | 16199537 | CNVD |
Williams Syndrome | 18923514 | CNVD |
Williams Syndrome | 20970697 | CNVD |
Williams-beuren syndrome | 20926892 | CNVD |
Williams-beuren syndrome | 21808859 | CNVD |
periventricular nodular heterotopia | 20648244 | CNVD |
Williams Syndrome | 20425783 | CNVD |
Williams-beuren syndrome | 22226172 | CNVD |
Williams-beuren syndrome | 18923513 | CNVD |
Williams-beuren syndrome | 17565757 | CNVD |
Williams-beuren syndrome | 18787571 | CNVD |
Williams Syndrome | 22241247 | CNVD |
Autism | 21686962 | CNVD |
Autism | 20970697 | CNVD |
Epilepsy | 22118685 | CNVD |
Epilepsy | 20970697 | CNVD |
Mental retardation | 19951919 | CNVD |
Mental retardation | 21686962 | CNVD |
Schizophrenia | 22118685 | CNVD |
Williams-beuren syndrome | 18337728 | CNVD |
language delay | 21686962 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Prostate cancer | 16573809 | CNVD |
Mental retardation | 16773131 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
Idiopathic infantile hypercalcaemia | 20466674 | CNVD |
Williams Syndrome | 18308711 | CNVD |
Williams Syndrome | 19255058 | CNVD |
Williams Syndrome | 18924169 | CNVD |
Williams Syndrome | 21939500 | CNVD |
Williams Syndrome | 20425784 | CNVD |
Williams Syndrome | 22241097 | CNVD |
Williams Syndrome | 19176822 | CNVD |
Williams Syndrome | 17505701 | CNVD |
Supravalvular aortic stenosis | 19844261 | CNVD |
Williams Syndrome | 16760918 | CNVD |
Williams-beuren syndrome | 18452001 | CNVD |
Williams-beuren syndrome | 19880526 | CNVD |
Autism | 17666889 | CNVD |
speech delay | 17666889 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:71803000-71812800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr7:71803600-71808200 | Weak transcription | H1 Cell Line | embryonic stem cell |
3 | chr7:71807000-71807600 | Enhancers | Thymus | Thymus |
4 | chr7:71807200-71810800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr7:71807400-71807800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
6 | chr7:71808000-71808200 | Bivalent Enhancer | ES-I3 Cell Line | embryonic stem cell |
7 | chr7:71808000-71810400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr7:71808200-71808800 | Enhancers | H1 Cell Line | embryonic stem cell |
9 | chr7:71808200-71809000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
10 | chr7:71808200-71809000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
11 | chr7:71808400-71809000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
12 | chr7:71808600-71809200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
13 | chr7:71808600-71809400 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
14 | chr7:71808600-71809400 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
15 | chr7:71808600-71809600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
16 | chr7:71808600-71809600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
17 | chr7:71808600-71809800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
18 | chr7:71808800-71809000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
19 | chr7:71808800-71809000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
20 | chr7:71809000-71813400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
21 | chr7:71809200-71813800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |